Marc Grasso, M.D.
Equibles does not estimate personal net worth.
Get an email with a short summary when Kyverna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get KYTX alertsAbout Marc Grasso, M.D.
Marc Grasso, M.D. is recorded as CFO at Kyverna Therapeutics, Inc. (KYTX) since June 30, 2025. Kyverna Therapeutics, Inc. reported in an 8-K filed June 30, 2025 that Marc Grasso, M.D. was appointed Chief Financial Officer, effective June 30, 2025. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyverna Therapeutics, Inc. includes Warner Biddle (CEO and Board Member), Christi Shaw (Chairman and Board Member), Greg Martini (CFO) and 7 others.
“Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, announced the appointment of Marc Grasso, M.D., as its Chief Financial Officer (CFO), effective today.”
Affiliation history
-
Current
2025-06-30–present
Company network
Leadership on record at Kyverna Therapeutics, Inc.
- Warner Biddle CEO, Board Member
- Christi Shaw Chairman, Board Member
- Greg Martini CFO
- Gregory Martini CFO, Chief Accounting Officer
- Marc Grasso CFO
- Mayo Pujols CTO
- Andrew Miller Board Member
- Andrew Miller, Ph.D. Board Member
- Beth Seidenberg Board Member
- Fred E. Cohen Board Member